Namita Thapar Will Get 293-Fold Return on Her Investment from This IPO
Namita Thapar stands to gain a remarkable 293-fold return on her initial investment.
New Delhi: Namita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately ₹ 127.87 crore from the company’s upcoming Initial Public Offering (IPO). The IPO, starting on Wednesday, July 3, will see Ms Thapar selling around 12.68 lakh shares through the Offer for Sale (OFS) component.
The IPO comprises a fresh issue worth ₹ 800 crore and an offer for sale of 1.14 crore equity shares from shareholders and promoters. Ms Thapar stands to gain a remarkable 293-fold return on her initial investment.
The Shark Tank India investor had acquired her shares at a weighted average price of ₹ 3.44 per share. With the top price band of the IPO set at ₹ 1,008 per share, her sale is expected to bring in nearly ₹ 127 crore.
Ms Thapar held over 63 lakh shares, or 3.5%, of the Pune-based pharmaceutical company as of March 2024. Her initial investment in these shares was ₹ 2.18 crore, with an average cost of acquisition per share of ₹ 3.44.
The IPO will close on Friday, July 5, with a price band ranging from ₹ 960 to ₹ 1,008 per equity share, each with a face value of ₹ 10.
Ms Thapar has also been reappointed as the Director of the board for an additional five years, effective July 28, 2024. The decision was approved by both the board and shareholders on May 27, 2024, and June 5, 2024, respectively.
Apart from Ms Thapar, other selling shareholders in the Offer for Sale (OFS) include promoters Satish Ramanlal Mehta, Sunil Rajanikant Mehta and Samit Satish Mehta.
Other shareholders participating in the OFS are BC Investments IV, Pushpa Rajnikant Mehta, Bhavana Satish Mehta, Kamini Sunil Mehta, Arunkumar Purshotamlal Khanna, Berjis Minoo Desai and Sonali Sanjay Mehta.
NEW DELHI: The Supreme Court directed Vodafone India to deposit Rs 2,000 crore with the department of telecommunications, paving the Read more
The Initial Public Offer (IPO) of ICICI Prudential Life Insurance Company Ltd — a first by an insurance entity — Read more
The proposal is unlikely to be challenged because all other existing investors, including Jack Ma’s Alibaba and subsidiaries that own Read more
Policybazaar, an online insurance aggregator supported by SoftBank Group, has requested an initial public offering of up to Rs 6,018 Read more
